Study on OMT-28 in Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation (AF)
Status:
Completed
Trial end date:
2020-03-20
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, dose-finding, placebo-controlled, parallel group,
multicenter, phase II study to evaluate the efficacy, safety, and popPK of three different
doses of OMT-28 given once daily versus placebo in patients with persistent AF.